Inhaled aztreonam lysine in the management of Pseudomonas aeruginosa in patients with cystic fibrosis: real-life effectiveness.

Inés Jiménez-LozanoCarmen Luna-ParedesEmilio Monte-BoquetAurora Fernández-PoloCarme Cañete-RamírezMaría Roch-SantedSilvia GartnerAntonio Álvarez-Fernández

Published in: European journal of hospital pharmacy : science and practice (2023)

infection, along with an adequate safety profile.

Keyphrases

pseudomonas aeruginosa
end stage renal disease
cystic fibrosis
newly diagnosed
ejection fraction
randomized controlled trial
chronic kidney disease
peritoneal dialysis
escherichia coli
acinetobacter baumannii
patient reported outcomes
drug resistant
multidrug resistant